Načítá se...
Secukinumab in the Treatment of Plaque Psoriasis in Patients with Malignancy
Although available data are conflicting, psoriasis seems to be associated with an increased baseline risk of malignancy. In addition, some antipsoriatic systemic treatments have been associated with risk of malignancy. There is not enough data on the association of interleukin (IL)-17 and IL-23 inhi...
Uloženo v:
| Vydáno v: | Case Rep Dermatol |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
S. Karger AG
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6816125/ https://ncbi.nlm.nih.gov/pubmed/31662733 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000501993 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|